207_Combined course Presentations
Overall Survival
40
35
M e d i
M e d i a n
35
30
30
25
a n
25
20
20
S u r v i v a l
15
S u r v i v a l
15
10
10
5
5
0
0
bradley 2010 cho 2009
gavila 379
choy 2000
videtic 765
ready 2010
saha pg497
chang 2011
kaplan 2004
nyman 2009
giorgio 2007
KONG haken
vokes 2007-1
socincki 2008
belani 2005-1
lawrence 2013-2 Hoang 2012-1
takayama 2013
el-hadaad 2013
rosenman 2002
schuette 2012-1
carter 2012-total
p=0.35
blumenschein 2011
bradley rt0g 0617-1
stinchcombe 2008 NOV
Study
Study
Cisplatin/Etoposide Weighted median survival = 19.4 months (N=2770)
Carboplatin/Paclitaxel Weighted median survival = 18.4 months (N=3602)
Steuer CE. et al. JAMA 2016;4280
Made with FlippingBook